No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations

Cystic fibrosis (CF) is an autosomal recessive disorder caused by many types of genetic defects, including premature stop codons. Gentamicin can suppress stop mutations in CF transmembrane conducatnce regulator (CFTR) in vitro and in vivo, leading to improvements in CFTR-dependent ion transport and...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Clancy, John P., Rowe, Steven M., Bebok, Zsuzsa, Aitken, Moira L., Gibson, Ron, Zeitlin, Pam, Berclaz, Pierre, Moss, Rick, Knowles, Michael R., Oster, Robert A., Mayer-Hamblett, Nicole, Ramsey, Bonnie
Médium: Artigo
Jazyk:Inglês
Vydáno: American Thoracic Society 2007
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1899350/
https://ncbi.nlm.nih.gov/pubmed/17347447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2006-0173OC
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky